An Unusual Case of the “Terrible Triad” in a Transgender Woman

With the increasing use of sodium-glucose cotransporter-2 inhibitors for type 2 diabetes and heart failure, clinicians need to understand how to treat euglycemic diabetic ketoacidosis (DKA), which is a potential side effect of the medication. The disease triad of euglycemic ketoacidosis, acute pancr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tirthani, Ekta, Said, Mina, Neupane, Binita, Quartuccio, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411995/
https://www.ncbi.nlm.nih.gov/pubmed/34513444
http://dx.doi.org/10.7759/cureus.16869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411995/
https://www.ncbi.nlm.nih.gov/pubmed/34513444
http://dx.doi.org/10.7759/cureus.16869

Ejemplares similares